TSC1 and familial pancreatic carcinoma: Consistent with this concept, our data demonstrates that RYGB surgery significantly attenuates the deficiency of TSC1 on mTORC1 activation in either the pancreatic cancer tissue or its neighboring normal pancreatic tissues.